ResearcherJeju National UniversityNo recent work listed
Dong Kee Jeong
Matched on ORCID iD 0000-0001-7908-3918; OpenAlex author ID A5008988412.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 3
2018: 1 paper · 2019: 1 paper
Papers 2
- BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling. Last author DOI 10.1155/2019/8620469↗
- SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. Last author DOI 10.1016/j.bbrc.2018.06.145↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Nisansala Chandimali · 2 shared papers, 2018–2019
- Paper BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic H… DOI 10.1155/2019/8620469↗
- Paper SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. DOI 10.1016/j.bbrc.2018.06.145↗
- Taeho Kwon · 2 shared papers, 2018–2019
- Paper BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic H… DOI 10.1155/2019/8620469↗
- Paper SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. DOI 10.1016/j.bbrc.2018.06.145↗
- Do Luong Huynh · 2 shared papers, 2018–2019
- Paper BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic H… DOI 10.1155/2019/8620469↗
- Paper SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. DOI 10.1016/j.bbrc.2018.06.145↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.